As part of the plan, Amazon has agreed to purchase 100,000 electric delivery vans from vehicle manufacturer Rivian.Technologyread more
At least in terms of monetary policy, Pence says should be taking after other regions who keep their benchmark interest rates near zero.Delivering Alpharead more
The plan will allow Medicare to negotiate lower prices on as many as 250 drugs and apply those discounts to private health plans.Health and Scienceread more
Hedge fund titan Leon Cooperman said he's concerned about a shift to the left in the political landscape, which could harm the economy and the stock market.Delivering Alpharead more
Apple's big iOS 13 update for iPhones is out now and includes lots of new features. Here's how to install it on your phone and what devices are supported.Technologyread more
The pilot program will deliver food and beverage, over-the-counter medications and other items within minutes, the company said. Prescription deliveries will not be available.Health and Scienceread more
The FDA's Office of Criminal Investigations opened a probe "shortly after" people started falling ill, Mitch Zeller, director of the FDA's Center for Tobacco Products, told...Health and Scienceread more
Investor Jim Chanos is betting against GrubHub, and said the food delivery company makes almost nothing per order.Delivering Alpharead more
Billionaire investor Leon Cooperman on Thursday said he believes that the Federal Reserve is "screwing the savers."Delivering Alpharead more
Datadog priced its stock at $27, selling 24 million shares and raising $648 million in its IPO.Technologyread more
"We sell the most mission-critical identity security to the largest global enterprises around the world," says Ping Identity CEO Andre Durand.Marketsread more
Shares of Gilead Sciences rose more than 1 percent Tuesday after its stock was upgraded by a firm that cited confidence in the prospects for Gilead's HIV treatments among other factors.
"We see a compelling buying opportunity in GILD at currently-depressed levels," said Jefferies analyst Brian Abrahams, who upgraded the drugmaker to a "buy" from a "hold."
The company has 11 listed, approved HIV treatments on the market, according to its website. Globally, more than 70 million people have been infected with the HIV virus since the beginning of the epidemic, according to the World Health Organization.
A spokesperson for Gilead did not immediately respond to CNBC's request for comment.
With Tuesday's gains, the stock is still down about 23 percent year-to-date.
GILD 2016 Chart